2-(3-(Methoxymethoxy)naphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-ylamine, 97.0%, 10g

3-(4-Bromophenyl)-isoxazole, 95.0%, 1g

6-FAM azide, min 95%, 10 mg, confezione di plastica.

2,3,5-Trichloro-6-hydroxybenzoic acid, 95.0%, 500g

(R)-Methyl 2-amino-2-cyclobutylacetate, 95%, 250mg

erythro-3-Methoxy-2-methyl-4-phenylbutyric Acid>95.0%(GC)100mg

(6-Fluoropyridin-3-yl)methanamine, 95.0%, 25g

(2S,3S)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one>96.0%(HPLC)(N)25g

6-Bromo-2,2'-bipyridyl>97.0%(GC)5g

1-Piperazinecarboxylic acid, 3-(cyanomethyl)-, phenylmethyl ester, (3R)-, 98%, 500mg

2-Methylbenzoyl cyanide, 95.0%, 5g

3-Fluoro-2-methylaniline>98.0%(GC)(T)5g